Kai Bao tech charts new course in bioconversion

The technology for producing artificial bear gall powder has made a great leap in China, with the Ministry of Science and Technology giving national support to the development of this technology by a company in Shanghai.

Shenzhen-listed Shanghai Kai Bao Pharmaceutical Co Ltd received central government funding of more than 5.31 million yuan ($850,100) for research into the key technology of cultivation of in vitro bear gall powder, along with a preclinical study that began in January and will end in December 2016, according to a company statement.

The local government of Shanghai will also grant the company some 6 million yuan. Kai Bao itself will invest 12 million yuan in the research, said the statement.